. 2018 May 18;42(2):975–987. doi: 10.3892/ijmm.2018.3695

Table III.

Results of LVEDV, LVEDD, LVESV and LVESD by echocardiography (n=5).

Group	LVEDV (µl)	LVEDD (mm)	LVESV (µl)	LVESD (mm)
Sham	226.22±48.92	5.68±0.54	81.21±15.12	3.25±0.33
IR	738.17±92.36^a	11.37±2.10^a	266.40±11.22^a	7.83±1.00^a
NC	739.10±89.25^a	11.40±2.00^a	267.40±11.12^a	7.84±1.10^a
miR-20b-5p mimics	939.25±111.32^a,^b,^c	31.40±2.00^a,^b,^c	366.40±11.22^a,^b,^c	10.83±1.00^a,^b,^c
miR-20b-5p inhibitors	414.79±89.25^a,^b,^c	8.47±2.02^a,^b,^c	116.45±45.04^a,^b,^c	5.62±2.23^a,^b,^c
si-Smad7	938.25±120.02^a,^b,^c	31.30±2.02^a,^b,^c	356.40±11.22^a,^b,^c	9.83±1.00^a,^b,^c
miR-20b-5p inhibitors + si-Smad7	733.17±110.23^a	11.39±2.00^a	270.40±11.22^a	7.90±1.00^a

P<0.05, compared with the sham group;

P<0.05, compared with the IR group;

P<0.05, compared with the miR-20b-5p inhibitors + si-Smad7 group. LVEDD, left ventricular diastolic diameter; LVESD, left ventricular systolic diameter; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; IR, ischemia-reperfusion; NC, negative control; miR-20b-5p, microRNA-20b-5p; Smad7, small mothers against decapentaplegic homolog 7; si-, small interfering RNA.